RenovoRx RNXT
NASDAQ RNXT
$1.60 +0.03 (+1.91%)
As of: Sep 30, 2026 · 3:02 PM EDT

RenovoRx (RNXT) Revenue (2025 - 2026)

Updated

RenovoRx's Revenue came in at $909,000 for Q2 2026, up 115.4% from $422,000 a year earlier and up 61.5% from the prior quarter.

Analysis

RenovoRx (RNXT) Revenue (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, RenovoRx reported Revenue of $1.98 million; for FY2025, it came in at $1.12 million.

  • Going back by year, Revenue was $43,000 in FY2024.
  • Business Quant data shows RNXT's Revenue at $563,000 (Q1 2026), $238,000 (Q4 2025) and $266,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 11.99 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 12.59 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 6.27 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 2.89 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 9.76 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 6.59 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 5.44 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 1.74 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 4.98 Bn
10 RenovoRx 70.84 Mn 70.84 Mn 766,000.00 909,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 909,000.00
Mar 31, 2026 563,000.00
Dec 31, 2025 238,000.00
Sep 30, 2025 266,000.00
Jun 30, 2025 422,000.00
Mar 31, 2025 197,000.00
API Access

RenovoRx Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=RNXT&period=max&api_key=YOUR_API_KEY